Today's Information

Provided by: ADIMMUNE CORPORATION
SEQ_NO 1 Date of announcement 2022/01/26 Time of announcement 13:37:43
Subject 
 Change to the research and development officer
of the company
Date of events 2022/01/26 To which item it meets paragraph 8
Statement 
1.Type of personnel changed (please enter: spokesperson, acting
  spokesperson, important personnel (CEO, COO, CMO, CSO, etc.)
,financial officer, accounting officer, corporate governance officer,
research and development officer, chief internal auditor, or
designated and non-designated representatives):Research and development
officer
2.Date of occurrence of the change:2022/01/26
3.Name, title, and resume of the previous position holder:Leo Leng,
Director/Research and development officer
4.Name, title, and resume of the new position holder:Dow Lee,
Director/Research and development officer
5.Type of the change (please enter: ��resignation��, ��position
adjustment��, ��dismissal��, ��retirement��, ��death�� or ��new
replacement��):Resignation
6.Reason for the change:Personal reason
7.Effective date:2022/01/26
8.Any other matters that need to be specified:None

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Adimmune Corporation published this content on 26 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 January 2022 05:45:08 UTC.